Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change TD Cowen analysts reiterated a Buy rating on Par Pacific Holdings, Inc. (NYSE:PARR) on July 21, 2026. Market Context Par Pacific Holdings, Inc.
Read moreRating Change Canaccord Genuity analysts reiterated a Buy rating on Progyny, Inc. (NASDAQ:PGNY) on July 21, 2026. Market Context Progyny, Inc.
Read moreRating Change Keybanc analysts reiterated a Overweight rating on ICU Medical, Inc. (NASDAQ:ICUI) on July 21, 2026. Market Context ICU Medical, Inc.
Read moreRating Change Morgan Stanley analysts downgraded BlackLine, Inc. (NASDAQ:BL) from Overweight to Equal-Weight on July 21, 2026. Market Context BlackLine, Inc.
Read moreRating Change Baird analysts reiterated a Neutral rating on Zions Bancorporation, National Association (NASDAQ:ZIONO) on July 21, 2026. Market Context Zions Bancorporation,…
Read moreRating Change TD Cowen analysts reiterated a Hold rating on Zions Bancorporation, National Association (NASDAQ:ZIONO) on July 21, 2026. Market Context Zions Bancorporation,…
Read moreRating Change Rosenblatt analysts reiterated a Buy rating on Calix, Inc. (NYSE:CALX) on July 21, 2026. Market Context Calix, Inc.
Read moreRating Change Canaccord Genuity analysts reiterated a Buy rating on Hinge Health, Inc. (NYSE:HNGE) on July 21, 2026. Market Context Hinge Health, Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on BellRing Brands, Inc. (NYSE:BRBR) on July 21, 2026. Market Context BellRing Brands, Inc.
Read moreRating Change Barclays analysts reiterated a Underweight rating on Choice Hotels International, Inc. (NYSE:CHH) on July 21, 2026. Market Context Choice Hotels International, Inc.
Read moreRating Change Stifel analysts reiterated a Hold rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) on July 21, 2026. Market Context ACADIA Pharmaceuticals Inc.
Read moreRating Change BMO Capital analysts reiterated a Outperform rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) on July 21, 2026. Market Context ACADIA Pharmaceuticals Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on Cousins Properties Incorporated (NYSE:CUZ) on July 21, 2026. Market Context Cousins Properties Incorporated…
Read moreRating Change Mizuho analysts reiterated a Outperform rating on Cousins Properties Incorporated (NYSE:CUZ) on July 21, 2026. Market Context Cousins Properties Incorporated…
Read moreRating Change Mizuho analysts reiterated a Neutral rating on Whirlpool Corporation (NYSE:WHR) on July 21, 2026. Market Context Whirlpool Corporation operates in the Consumer…
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on Halozyme Therapeutics, Inc. (NASDAQ:HALO) on July 21, 2026.
Read moreRating Change Mizuho analysts reiterated a Outperform rating on Vornado Realty Trust (OTC:VNORP) on July 21, 2026. Market Context Vornado Realty Trust operates in the Real Estate…
Read moreRating Change Barclays analysts reiterated a Underweight rating on Vornado Realty Trust (OTC:VNORP) on July 21, 2026. Market Context Vornado Realty Trust operates in the Real…
Read moreRating Change Morgan Stanley analysts reiterated a Underweight rating on Sirius XM Holdings Inc. (NASDAQ:SIRI) on July 21, 2026. Market Context Sirius XM Holdings Inc.
Read moreRating Change BMO Capital analysts initiated coverage on Axsome Therapeutics, Inc. (NASDAQ:AXSM) with a Outperform rating on July 21, 2026. Market Context Axsome Therapeutics, Inc.
Read more
